Showing results (51-60 of 886) with videos related to

Sort By:
Pageof 89
Scandinavian Journal of Urology|January 3, 2018
Lesion size on prostate magnetic resonance imaging predicts adverse radical prostatectomy pathologyPanu P Tonttila, Mari Kuisma, Eija Pääkkö, et al.
Scandinavian Journal of Urology|January 10, 2019
The prognostic impact of incidental prostate cancer following radical cystoprostatectomy: a nationwide analysisSimon Jønck, John Thomas Helgstrand, Martin Andreas Røder, et al.
Scandinavian Journal of Urology|January 3, 2019
The effect of preoperative nefopam treatment on postoperative catheter-related bladder discomfort in patients undergoing transurethral bladder tumor resection: a randomized double-blind studyMiHye Park, Chan Hee Jee, Kyung-Hwa Kwak, et al.
Scandinavian Journal of Urology|October 31, 2019
Educational level and first-time PSA testing in general practiceCaroline Sophie Lerhmann-Lerche, Signe Benzon Larsen, Ingelise Andersen, et al.
Scandinavian Journal of Urology|January 31, 2019
Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohortAino Siltari, Teemu J Murtola, Kirsi Talala, et al.
Scandinavian Journal of Urology|December 24, 2019
Does renal mass biopsy influence multidisciplinary treatment recommendations?Jennifer M Lobo, Matthew B Clements, Daniel P Bitner, et al.
Scandinavian Journal of Urology|December 14, 2019
Venous thromboembolism after radical cystectomy and urinary diversion: a single-center experience with 1737 consecutive patientsMahmoud Laymon, Ahmed Harraz, Ahmed Elshal, et al.
Scandinavian Journal of Urology|February 25, 2018
Choline-phosphate cytidylyltransferase-α as a possible predictor of survival and response to cisplatin neoadjuvant chemotherapy in urothelial cancer of the bladderTammer Hemdan, Polat Turker, Per-Uno Malmström, et al.
Scandinavian Journal of Urology|February 22, 2018
Results of 14 years of brachytherapy for localized prostate cancer in Denmark: the Herlev cohortMikael G Jacobsen, Frederik B Thomsen, Mikkel Fode, et al.
Scandinavian Journal of Urology|February 22, 2018
The combination of targeted and systematic prostate biopsies is the best protocol for the detection of clinically significant prostate cancerAlexandre Fourcade, Charlotte Payrard, Valentin Tissot, et al.
Pageof 89